Matt OBrien
Stock Analyst at Piper Sandler
(3.01)
# 1,454
Out of 4,996 analysts
8
Total ratings
87.5%
Success rate
40.39%
Average return
Main Sectors:
Stocks Rated by Matt OBrien
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HTFL HeartFlow | Initiates: Overweight | $38 | $33.06 | +14.94% | 1 | Sep 2, 2025 | |
| MMSI Merit Medical Systems | Maintains: Overweight | $55 → $62 | $80.20 | -22.69% | 6 | Oct 29, 2020 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $70 → $90 | $12.00 | +650.00% | 1 | Feb 25, 2020 |
HeartFlow
Sep 2, 2025
Initiates: Overweight
Price Target: $38
Current: $33.06
Upside: +14.94%
Merit Medical Systems
Oct 29, 2020
Maintains: Overweight
Price Target: $55 → $62
Current: $80.20
Upside: -22.69%
Tandem Diabetes Care
Feb 25, 2020
Maintains: Overweight
Price Target: $70 → $90
Current: $12.00
Upside: +650.00%